A new report from the World Health Organization (WHO) shows that there is a big difference in the amount of antibiotics consumed by countries around the world, and urged changes in the way they monitor and use antimicrobial agents.
"Without effective antibiotics and other antimicrobials, we will lose the ability to treat common infections such as pneumonia," said Dr. Hansen, who is the director of WHO's Essential Medicines and Health Products Division Suzanne Hill said.
The report found 65 antimicrobial use data on a Defined Daily Dose (DAD) basis for every 1000 people per day that found antimicrobial consumption to be almost 15 times the difference between the countries that consume the most and the smallest countries.
Antibiotic usage in Burundi was only 4.44 DDD / 1000 residents per day, to 64.41 DDD / 1000 in Mongolia, and between high-income countries such as Canada (17.05 DDD / 1000) and Korea (27.68 DDD / 1000).
"A large difference in the use of antibiotics globally is that some countries have overused antibiotics, while other countries do not have sufficient access to these life-saving drugs," WHO said.
According to the WHO, in Europe, where the median antibiotic consumption was 17.9 DDD / 1000 per day, the report found a four-fold difference between the highest and lowest levels of antibiotic consumption.
In the future, WHO says it is important for countries to implement a national monitoring system for antibiotic use and policies to ensure that antibiotics are used appropriately.
The report also shows that consumption rates differ depending on the type of antibiotic. The World Health Organization has used antibiotics that are widely used worldwide, such as amoxicillin and amoxicillin / clavulanic acid, which recommend first or second treatment for many common infections, which should be used wisely than WHO. In some countries, antibiotics Use 50%.
The report, however, reports that many low- and middle-income countries do not use antibiotics that WHO claims should be secured as a last resort for certain infectious or multidrug-resistant bacteria.
"Some countries may not have access to these drugs, which are necessary for the treatment of multidrug-resistant infections," the WHO said. In contrast, countries such as Italy and Spain reported more frequent use of antibiotics than others in the report.
According to WHO, WHO is making efforts to collect data on antibiotic consumption to change the way it monitors and controls antibiotic consumption in some countries, including Bangladesh and Cote d'Ivoire.
"In the process of national surveillance of antibiotic consumption, each country looked at the procurement and supply chain of pharmaceuticals as a starting point for strengthening the overall pharmaceutical system.